Cochran M, Peacock M, Sachs G, Nordin B E
Br Med J. 1970 Jan 17;1(5689):135-7. doi: 10.1136/bmj.1.5689.135.
Porcine calcitonin in a slow-release gelatin vehicle was given by intramuscular injection to 10 patients-four with primary hyperparathyroidism, four with Paget's disease, and two with carcinoma of the breast and hypercalcaemia. All cases showed a fall in serum calcium with an immediate rise in urine calcium. All except three patients with primary hyperparathyroidism showed a fall in serum phosphorus, but an immediate rise in urine phosphorus occurred in all cases. Urine hydroxyproline output fell in three patients with severe Paget's disease. Urine sodium rose in all cases, but the effects on potassium, magnesium, water, and pH were not appreciably different from results obtained in four control subjects who were given the gelatin vehicle alone.The data suggest that calcitonin caused a decrease in the tubular resorption of calcium and phosphorus. The hypocalcaemic effect appeared to be due to a decrease in bone resorption in the patients with Paget's disease but in the remaining cases could be accounted for in part or entirely by the rise in urine calcium.
将缓释明胶载体中的猪降钙素通过肌肉注射给予10例患者,其中4例患有原发性甲状旁腺功能亢进,4例患有佩吉特病,2例患有乳腺癌并伴有高钙血症。所有病例血清钙均下降,尿钙立即升高。除3例原发性甲状旁腺功能亢进患者外,所有患者血清磷均下降,但所有病例尿磷均立即升高。3例严重佩吉特病患者尿羟脯氨酸排出量下降。所有病例尿钠均升高,但对钾、镁、水和pH值的影响与仅给予明胶载体的4例对照受试者的结果无明显差异。数据表明,降钙素导致肾小管对钙和磷的重吸收减少。低钙血症效应在佩吉特病患者中似乎是由于骨吸收减少所致,但在其余病例中,部分或全部可由尿钙升高来解释。